Side-by-side comparison of AI visibility scores, market position, and capabilities
Morgan Stanley-owned (MS, $13B acquisition 2020) online brokerage with commission-free trading and advanced options platform; competing with Fidelity, Schwab, and Robinhood for retail investor brokerage.
E*TRADE is a Morgan Stanley-owned online brokerage and financial services platform providing self-directed investors with commission-free stock and ETF trading, options and futures trading, retirement accounts (IRAs, Roth IRAs), managed portfolios, and banking services through web and mobile platforms. Founded in 1982 in Menlo Park and one of the pioneers of retail online trading, E*TRADE was acquired by Morgan Stanley (NYSE: MS) for $13 billion in October 2020, integrating E*TRADE's retail brokerage with Morgan Stanley's wealth management business.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.